The American Cancer Society (ACS) recommends men have the opportunity to make an informed decision about screening for prostate cancer (PCa). The ACS developed a unique decision aid (ACS-DA) for this purpose. However, to date, studies evaluating the efficacy of the ACS-DA are lacking. The authors evaluated the ACS-DA among a cohort of medically underserved men (MUM). METHODS: A multiethnic cohort of MUM (n 5 285) was prospectively included between June 2010 and December 2014. The ACS-DA was presented in a group format. Levels of knowledge on PCa were evaluated before and after the presentation. Participants' decisional conflict and thoughts about the presentation also were evaluated. Logistic regression analyses were performed to determine factors associated with having an adequate level of knowledge. RESULTS: Before receiving the ACS-DA, 33.1% of participants had adequate knowledge on PCa, and this increased to 77% after the DA (P <.0001). On multivariate analysis, higher education level (odds ratio, 11.19; P 5.001) and history of another cancer (odds ratio, 7.45; P 5.03) were associated with having adequate knowledge after receiving the DA. Levels of decisional conflict were low and were correlated with levels of knowledge after receiving the DA. The majority of men also rated the presentation as favorable and would recommend the ACS-DA to others. CONCLUSIONS: Use of the ACS-DA was feasible among MUM and led to increased PCa knowledge. This also correlated with low levels of decisional conflict. The ACS-DA presented to groups of men may serve as a feasible tool for informed decision making in a MUM population. Cancer 2017;123:583-91.
INTRODUCTION
Prostate cancer (PCa) is the most common cancer among men in the United States, with an estimated 221,000 cases and 27,500 deaths in 2015. 1 Screening and early detection of PCa mainly relies on prostate-specific antigen (PSA) testing and digital rectal examination (DRE); however, both of these tests are imperfect screening tools. Given the uncertainty related to the magnitude of benefit in mortality reduction versus harms caused by screening, the US Preventive Services Task Force (USPSTF) has recommended against PSA screening for the general population. 2 The American Cancer Society (ACS) recommends that men should learn about the potential benefits and harms of screening and decide whether screening is right for them. 3 Similarly, the American Urological Association (AUA) has recommended against routine screening and recommends shared decision making for men ages 55 to 69 years based on a man's values and preferences. 4 Decision aids (DAs) are tools developed to educate patients about possible benefits and harms of a medical condition and to help them with their decision on potential options. [5] [6] [7] DAs for PCa screening have been developed, and their role in increasing patients' level of knowledge, decreasing decisional conflict, and their impact on screening behaviors have been evaluated in several studies. [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] Results from those studies mainly indicate an increased level of knowledge, but decreased decisional conflict could not be established in some of the studies. 13, 14, 26 In 2010, the ACS developed a unique DA, the ACS Prostate Cancer Early Detection Decision Aid (ACS-DA), to aid in providing the essential components of information related to discussing the risks and benefits of PCa early detection. The DA was developed to support their recommendations for the early detection of PCa cancer. 3 We are unaware of subsequent publications using the DA to evaluate its performance in promoting informed screening decisions.
In this study, we evaluated the efficacy of the ACS-DA in group of medically underserved men (MUM) who were candidates for PCa screening. We also wanted to assist them with defining their preferences. Herein, we extend our prior observations among MUM while also assessing compliance with follow-up recommendations among indigent participants who were engaged in the Harris Health Care System (HHS) in Texas.
MATERIALS AND METHODS

Participants and Recruitment
Participants were prospectively included in the study from June 2010 through December 2014. The target population was an indigent male population between ages 40 and 70 years who were patients within the HHS in Harris County, Texas. The Settegast Clinic within the HHS was the recruitment site for the project and serves a largely medically underserved African American (AA) and Hispanic population.
Men were invited to participate in a PCa education session in 1 of 2 ways: 1) men visiting the Settegast clinic for other reasons were invited by flyer to participate in a PCa education and early detection session using the ACS-DA, or 2) clinic physicians who were aware that the free education sessions were available referred men to participate in the sessions.
Development of the ACS-DA
The DA was developed by ACS staff and volunteers in conjunction with the publication of the 2010 ACS guideline for PCa early detection. 3 The 2010 guideline recommends an informed decision-making approach for men who may be eligible for PSA-based screening, and the publication includes a section detailing key information on the potential benefits and harms of PSA screening that should be shared with patients as part of the informed decision-making discussion. The ACS PCa guideline development committee also recommended that ACS develop a simple DA to assist clinicians with this discussion. 3 The DA was developed by ACS staff and the guideline committee's informed decision-making expert (R.J.V.), with ongoing feedback from the guideline development committee. The ACS-DA content was written at a 5 th -grade reading level. PCa statistics and other numeric information were presented in a simplified fashion through the use of graphics and illustrations. The nearfinal version of the DA then underwent a qualitative evaluation by 31 men of diverse racial and ethnic origins (40% AA, 40% Caucasian, and 20% Hispanic). Twothirds of the men had incomes <$25,000 annually, and one-third were judged to have marginal or poor literacy. After reading the draft DA, the men underwent 1-on-1 interviews designed to assess their understanding of important facts about PCa screening, readability, perceived biases in the presentation of the information, usefulness of the information, and the main idea, ie, PCa testing is a choice, and each man should decide whether testing is right for him. Overall, respondents viewed the DA very positively, judged that the information on benefits and harms was presented in a balanced manner, and believed that, after reading it, they had a heightened awareness of and increased information about PCa and testing for the disease. These reviewers provided several suggested edits and modifications that were incorporated into the final version of the ACS-DA (for the focus group summary of findings [Supporting Fig. 1 ] and the Final Decision Aid, see online supporting information).
Data Collection
Participants' data were collected prospectively under an Institutional Review Board-approved tissue/data collection protocol related to procuring serum/tissue/data among MUM who were considering early detection for PCa. Data were retrospectively analyzed using a second protocol-specific Institutional Review Board approval related to assessment of the ACS-DA. Demographic data, including age, race, level of education, type of insurance, smoking, occupational risk factors, previous PCa screening, family history of PCa, and lower urinary tract symptoms, were collected. Participants subsequently received a questionnaire of 11 questions (Supporting Table 1 ; see online supporting information) to determine their baseline knowledge about PCa. The questionnaire was modified from 2 previous studies. 27, 28 Participants who answered at least 8 of the 11 survey questions correctly were designated as having adequate PCa knowledge. Participants were then provided the ACS-DA using a Power Point presentation, and their PCa knowledge was tested a second time. Note that we made the decision to use a Power Point version of the DA to facilitate group education sessions and to reduce potential barriers to participation. The presentation was given by a Harris Health Education Specialist who was not involved as a part of the Original Article research team. The sessions included from 2 to 14 men, and the average attendance was approximately 8 men.
After the DA presentation, participants were asked about their decision to undergo screening. In addition, they were asked to complete a 10-question decisional conflict scale, which assessed uncertainty and whether men felt informed, had clarity on the information, and felt supported. 29 The decisional conflict scale was scored from 0 to 100, with higher scores indicating higher levels of decisional conflict. Men with scores 25 were considered to have low decisional conflict. Another 5-question survey was given to evaluate the presentation focusing on the amount of information given, the length of the presentation, and the clarity and balance of information (ie, whether or not the presentation appeared to favor screening). Finally, the men were asked to answer 3 questions about their personal opinions regarding a PCa diagnosis, possible regret about their decision on getting tested, and future loss of erectile functions if they had treatment. The first question was, "If you had prostate cancer, would you want to know?"; the second question was, "If you decided to not be tested for prostate cancer, and then you later developed prostate cancer, would you regret your decision?"; and the third question was, "If you were to lose your ability to have an erection, what would it mean to you?"
Screening and Early Detection Procedures
Participants who decided to get screened underwent serum PSA testing and DRE free of charge. Those who had abnormal PSA levels (defined as 2.5 ng/mL) and/or abnormal DRE results (the presence of induration and/or frank nodules) were contacted to provide them with a clinic appointment for further counseling and possible prostate biopsy.
Statistical Analysis
Participants' characteristics were summarized using median (range) values for continuous variables and frequency (percentage) values for categorical variables. The agreement between pretest and posttest scores was assessed using the McNemar test. Univariate and multivariate logistic regression analyses were performed to assess the association between having adequate knowledge (ie, correctly answered 8 of 11 questions) and other characteristics. Exact logistic regression analysis was performed when some cells formed by the outcome and categorical predictor variable had no observations. The Fisher exact test was used to analyze the association of the decisional conflict score with pretest and postpresentation levels of knowledge. All statistical analyses were performed in SAS version 9.3 (SAS Institute Inc., Cary, NC).
RESULTS
Two hundred eighty-five men were included in the study. The mean ( 6 standard deviation) age of the population was 57 6 7.9 years (range, 35-84 years). Characteristics of the population are summarized in Table 1 . AA men comprised 73.1% of the population, and 75.8% of participants had the equivalent of a high school degree or less education. The median annual income of the cohort was <$15,000.
Before receiving the DA, PCa knowledge was evaluated in 239 men; 79 (33.1%) had adequate knowledge about PCa (ie, 8 correct answers). The median number of correct answers was 6 (range, 0-11 correct answers). After receiving the DA, 226 men took the posttest, and 174 (77%) had adequate knowledge, with median of 9 correct answers (range, 1-11 correct answers). The improvement in the proportion of men with adequate PCa knowledge was statistically significant (P < .0001).
None of the participants' characteristics were associated with having adequate knowledge before receiving the DA. However, having an education level higher than high school (odds ratio [OR], 10.15; 95% confidence interval [CI], 2.38-43.38; P 5 .002) and having a history of another type of cancer (OR, 6.43; 95% CI,1.34 to infinity; P 5 .04) were associated with adequate PCa knowledge after receiving the DA in the univariate logistic regression analysis. The results from logistic regression analysis are summarized in Table 2 . These 2 factors were then included in a multivariate logistic regression analysis, and both the level of education (OR, 11.19; 95% CI, 2.61-47.93; P 5 .001) and a history of another type of cancer (OR, 7.45; 95% CI,1.52 to infinity; P 5 .03) were significantly associated with adequate PCa knowledge after receiving the DA.
After they received the DA, the decision to undergo screening could be evaluated in 218 participants. Two hundred six (94.5%), 8 (3.7%), and 4 (1.8%) of the participants stated that they wanted to be tested, were unsure, or did not want to be tested for PCa, respectively. The mean ( 6 standard deviation) decisional conflict score of the population was 7.9 6 14.5, and scores on the uncertainty, informed, values clarity, and support subscales were 3.5 6 12.5, 12.7 6 24.9, 6.7 6 19.7, and 6.9 6 17.2, respectively. The decisional conflict scale score had a significant correlation with the postpresentation level of knowledge in the total score and all subscales except the Results of the ACS-DA for PCa Screening/G€ okce et al Cancer February 15, 2017 uncertainty and support subscales. The results are summarized in Table 3 .
Most participants also rated the presentation favorably in terms of the amount, length, clarity, and balance of information and would recommend it to others. However, participants also were asked about their opinion of the presentation in terms of its balance, and 43.4% stated that it was clearly slanted to favor screening. The questions and summary of answers are presented in Table 4 .
Participants' responses to the questions on their values were as follows: 212 of 218 men (97.2%) stated that they would like to know whether they had PCa; 189 of 217 (87.1%) stated that they would greatly regret or would have some regret about their decision to not get tested if they were diagnosed with PCa later; and 46 of 216 (21.3%) stated that loss of erectile function would be a minor adjustment for them, whereas 25% stated that they might never adjust to it, and 53.7% stated that it would be bad but they could adjust to it.
Two hundred eighty-one men (98.5%) ultimately signed an informed consent to have a PSA test performed as a part of the Prostate Outreach Project (POP) enrollment. The median serum PSA level was 0.9 ng/mL (range, 0.1-10.7 ng/mL). DRE was performed in 180 men, and 29 (16.1%) had abnormal results. Either an abnormal DRE or an abnormal serum PSA was noted in 51 of the 281 men (18.1%) who underwent PSA testing and/or DRE. Four men were lost to follow-up, and the remaining 47 men were contacted and given an appointment. Thirty-seven of those 47 participants (78.7%) kept their appointment. An additional 10 men were given an appointment for their lower urinary tract symptoms, and 9 of these men also kept their appointment. The overall compliance rate was 80.7% with a follow-up appointment. After the clinic visit, 16 men underwent a prostate biopsy, and 6 of those 16 biopsied men (37.5%) exhibited PCa. Reasons for not undergoing biopsy included a repeat DRE with normal results and physician or patient preference to follow serial serum PSA levels over time.
DISCUSSION
PSA-based screening in the general population has been debated, and the USPSTF has recommended against routine PSA screening. 2 Both the ACS and the AUA recommend informed decision making before PCa screening. 3, 4 The ACS developed a DA for this particular purpose; however, to our knowledge reports, of its use have not been published to date. In this study, we used the ACS-DA in the form of a presentation, and the results support a significant improvement in participants' level of knowledge on harms and benefits of PCa screening. The DA was well accepted by the participants, and low decisional conflict scores were maintained in a population of MUM.
In our cohort, 33.1% of participants had adequate baseline knowledge, and this rate increased to 77% after The level of increase in PCa knowledge depends on many factors, such as baseline level of knowledge, educational status of the population, the type of DA (Web-based, print, or presentation), and the content of the DA. For instance, in the study by Ashorobi et al, we previously reported that 17% of participants had adequate levels of knowledge, and this increased to 58% after using a video-format educational tool that was written at a 10th-grade reading level. 31 In the current study, the ACS-DA, which was developed for a 5th-grade reading level, was presented to participants in a unique Power Point form and mediated a higher rate of men with adequate knowledge. Although both studies were performed in the community setting and had >60% AA male participants, the current study represents men who presented at a health clinic for services. The previous study by Ashorobi and colleagues included a more unselected cohort of AA underserved men, in that 40% had no physician, and 50% were uninsured. Thus, differences in baseline and posttest knowledge were likely mediated by multiple factors, including the study population, educational content, reading level, and method of presentation.
In the study by Magnus, income level and having a family member with history of PCa were associated with higher levels of PCa knowledge. 32 Similarly, in the study by Weinrich et al, family income was associated with PCa screening knowledge in a population of men of mostly AA origin. 33 In the study by Ashorobi et al, AA race, an education level greater than high school, a positive family history of PCa, possession of insurance, and previous PCa testing were associated with adequate levels of knowledge. 31 However, in the current study, we could not identify any of the factors associated with an adequate level of knowledge. This may be because of the relatively lower number of participants in the current study. In addition, we accepted 8 correct answers to 11 questions as an indication of adequate knowledge, but it was 8 correct answers to 10 questions in the study by Ashorobi et al. 31 Therefore, the threshold for adequate knowledge was somehow lower in the current study, and this may explain the disparity in the baseline rate of men with adequate knowledge and the factors associated with adequate knowledge.
Patient education related to PCa screening is especially important for men in medically underserved populations, particularly those of Hispanic and AA ethnicity. In a population-based survey, rates of PCa screening test use were evaluated. Men of Hispanic and AA ethnicity, in addition to men with less than a high school education or with a low income level, had the lowest prevalence of PCa screening. 34 Miller et al also noted that, contrary to the general population, the rate of clinically insignificant, low-stage PCa does not increase in the low-income, uninsured population. 35 Therefore, under-detection and under-treatment are still significant problems in this population. This is especially relevant because the studies used as a data source for the USPSTF recommendations had few AA men. 2 Given this dilemma, it becomes even more important to provide AA and other underserved populations with information about the risks and benefits of PCa early detection so they can make informed decisions about testing.
After the presentation, we observed that participants' decisional conflict levels were low. This was concordant with the previous studies that reported decreased decisional conflict after individuals received a DA. 8, [10] [11] [12] [13] 15, 18, 22, 30 Decisional conflict levels also were correlated with levels of knowledge after the presentation, in that those who had adequate knowledge also tended to have low decisional conflict levels. In their study, Taylor et al reported mean decisional conflict scores of 10.7 and 11.4 for their groups of patients who received print-based and Web-based DAs, respectively. 22 The mean decisional conflict score after the presentation was 7.9 in the current study, which was slightly lower but consistent with the findings of Taylor et al. 22 The amount of information given in the presentation, the length of presentation, and the clarity of the information all were scored satisfactory by the participants. In addition, 96.4% of participants stated that they would recommend the presentation to others facing this decision. However, 43.4% of participants stated that the presentation was clearly slanted to favor testing. This contrasted with the statement by nearly one-half of participants that the DA was completely balanced. This was not explained by different presenters, because more >90% of the sessions were provided by the same education specialist. Because the material was presented to the men versus self-administered, we also cannot determine whether this was related to the presenter or the material. A similar schism was recorded in the qualitative evaluation of a selfadministered version of the DA during its development. Most participants perceived the tool as presenting the pros and cons of screening in a balanced fashion, but others felt that the tool was "proscreening." This issue raises an item for further study to determine the optimal use of the ACS-DA among various cohorts of men.
An abnormal screening event was observed in 18.1% of the screened patients, and this was similar to the 14% rate in the study by Ashorobi et al. 31 However patient compliance was 80.7% in the current study, which was double the 40% rate of adequate follow-up in the study by Ashorobi et al. 31 One obvious difference in the 2 populations was that, in the current study, participants already were engaged with the health care system when they were recruited to be a part of the study. This was not the case in our previous study, in which 50% were uninsured, and 40% had no physician. Although we provided navigated assistance in attempting to bring the participants from the study reported by Ashorobi et al into the system, barriers to their participation included incorrect contact information, unaware that they were lost to follow-up, or stating that they wanted to see other physicians. Because participants in the current study were already engaged in a health care system, follow-up was facilitated.
Although the current study provides unique evidence regarding use of the ACS-DA for informed decision making, it has several limitations. The DA was given as a Power Point presentation rather than by selfadministration. Although we believed this would improve compliance and the ease of providing the information to this MUM cohort, we may have introduced a bias related to presenting the material itself. Another important point is that participants' levels of decisional conflict were evaluated only after the presentation. We do not know their decisional conflict levels before the intervention, and it is possible that many had already made a decision about screening. Notwithstanding these limitations, the data support our findings that the DA did improve knowledge and that such an improvement in knowledge was associated with lower decisional conflict.
Another important limitation of the study relates to the selection of patients for PCa early detection. Both the AUA and the ACS recommend the avoidance of screening in men who have less than a 10-year life expectancy. Comorbid conditions among this study population include diabetes, heart disease, hypertension, and prior stroke. Although all participants were ambulatory and did not appear to have any obvious limitations during their clinic visit, we cannot be certain that they all had an anticipated 10-year life expectancy. Thus, some of our patients may have eventually undergone screening inappropriately. Because some patients were not referred by their primary care providers, this may have affected that group of men more significantly. On the basis of current guidelines, we agree that the DA is optimally used in conjunction with the physician in men who are referred by their physicians and have an anticipated life expectancy >10 years. The appropriately educated patient and physician can then make a final decision about whether or not to be screened. This is relevant, because the DA itself does not provide information on how life expectancy might affect a decision for PCa screening, but it does urge patients to speak with their physicians about screening. In this regard, there are several online tools that can assist physicians in determining the likelihood of a patient's survival at 5 to 10 years, factoring in their medical history. [36] [37] [38] Notwithstanding the above-described limitations, to our knowledge, this is the first study reporting on use of the ACS-DA. The successful use of the DA among an indigent cohort of men with a low educational level speaks to its potential utility as an educational tool in busy outpatient settings, in which primary care physicians may feel overburdened or uncomfortable with their existing knowledge base to counsel their patients. 39 Future studies should prospectively evaluate the optimal method for administering the DA among diverse populations of men while measuring baseline variables related to existing knowledge and attitudes about PCa detection and treatment as well as decisional conflict.
Conclusions
Use of the ACS-DA in the form of a presentation among a multiethnic underserved cohort was feasible in a clinic setting. The ACS-DA presentation lead to increased PCa knowledge, and this was directly correlated with low levels of decisional conflict with respect to PCa early detection. These results suggest that the ACS-DA, given in the form of a presentation, is a feasible tool for informed decision making in this cohort and should be further evaluated as a model for educating men about PCa early detection before testing.
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